IFP Advisors’s Bioventus BVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.08K Sell
220
-19
-8% -$181 ﹤0.01% 4217
2026
Q1
$2.18K Sell
239
-3
-1% -$25 ﹤0.01% 3927
2025
Q4
$1.8K Buy
242
+7
+3% +$50 ﹤0.01% 3877
2025
Q3
$1.57K Sell
235
-7
-3% -$49 ﹤0.01% 3788
2025
Q2
$1.6K Buy
242
+232
+2,320% +$1.65K ﹤0.01% 4001
2025
Q1
$92 Hold
10
﹤0.01% 3870
2024
Q4
$105 Buy
+10
New +$118 ﹤0.01% 4010
2023
Q3
Sell
-7,205
Closed -$20.8K 3332
2023
Q2
$20.8K Hold
7,205
﹤0.01% 1973
2023
Q1
$138K Buy
+7,205
New +$13.8K 0.01% 1096

Other funds holding BVS

IFP Advisors's BVS Position: Q2 2026 in Review

IFP Advisors reduced its Bioventus (BVS) stake by 7.9% in Q2 2026, selling an estimated $181 and leaving 220 shares worth $2.08K. The position accounts for ﹤0.01% of the portfolio, ranked #4217.

IFP Advisors first reported a position in BVS in Q1 2023 and has held it in 9 quarters since. The position peaked at $138K in Q1 2023. 156 funds tracked by Wall St. Rank hold BVS as of Q2 2026.

  • IFP Advisors held 220 shares of Bioventus worth $2.08K as of Q2 2026.
  • IFP Advisors sold 19 Bioventus shares in Q2 2026, an estimated $181.
  • Bioventus made up ﹤0.01% of IFP Advisors's portfolio in Q2 2026, its #4217 holding.
  • IFP Advisors first reported a position in Bioventus in Q1 2023 and has held it in 9 quarters since.
  • IFP Advisors's Bioventus position peaked at $138K in Q1 2023.
  • 156 funds tracked by Wall St. Rank held Bioventus as of Q2 2026.

Based on IFP Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.